Applications of 5-Chloro-3-Methyl-1-Phenylpyrazole in Industrial Manufacturing

5-Chloro-3-Methyl-1-Phenylpyrazole is a critical specialty intermediate manufactured at industrial scale for precision downstream synthesis. Its distinct molecular framework drives reactivity in strictly limited, high-value application scenarios. Below, we outline the principal sectors, process integration, compliance requirements, recommended usage ranges, and final product forms secured through our advanced production standards.

1. Agrochemical Active Ingredient Precursor for Modern Pyrazole Herbicides

Leading crop protection manufacturers use 5-Chloro-3-Methyl-1-Phenylpyrazole as a core intermediate for synthesizing certain pyrazole-based selective herbicide actives. This pyrazole building block enables the targeted construction of active moieties critical to high performance in weed resistance programs within the agricultural industry. Our product supports consistent yield throughout the multi-step synthesis, ensuring purity and reactivity benchmarks required by agrochemical registration authorities.

Industry compliance standards

• EU REACH Registration (EC No. 1907/2006) for intermediates
• CropLife International Stewardship Guidelines
• OECD Good Laboratory Practice (GLP) for pesticide actives
• China Ministry of Agriculture Pesticide Registration Regulation GB 4839-2009

Typical usage ratio

• 15–25% of total molar input during active intermediate coupling; exact proportion depends on target herbicide molecule and scaling protocol

Downstream process integration

• Direct input in nucleophilic aromatic substitution or cyclization stages during herbicide active core assembly

Final product types

• Pre-emergence and post-emergence selective herbicides including pyrazole-derived active premixes

2. Pharmaceutical Intermediate for Antipyretic and Analgesic Drug Synthesis

Specialty pharmaceutical synthesis routes rely on 5-Chloro-3-Methyl-1-Phenylpyrazole as a key intermediate for constructing pyrazole-containing drug scaffolds. These include selective cyclooxygenase inhibitors and new-generation analgesics, leveraging the core pyrazole ring to achieve target enzyme modulation. Our strict QC provides consistent assay results crucial for downstream process validation and regulatory dossier submissions.

Industry compliance standards

• United States Pharmacopeia (USP) for intermediate specifications
• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR Part 211 (US FDA cGMP for finished pharmaceuticals)
• European Pharmacopoeia (EP) monographs where applicable

Typical usage ratio

• 10–20% in the synthetic sequence; determined by molar design for target API and scale of the batch

Downstream process integration

• Incorporation during heterocycle formation—typically via condensation or amination reactions—prior to final synthetic steps of the drug compound

Final product types

• Analgesic and antipyretic bulk APIs containing the pyrazole motif
• Finished oral and parenteral pharmaceutical formulations

3. Fine Chemical Intermediate for Dye and Pigment Manufacturing

In the colorants industry, 5-Chloro-3-Methyl-1-Phenylpyrazole functions as an essential intermediate in the design of high-stability azo dyes and specialty pigments, imparting colorfastness, thermal robustness, and distinct tinctorial characteristics. The aromatic-chlorine and methyl functionalities support downstream coupling and diazo processes, enabling targeted molecular tuning of finished color additives used in demanding environments.

Industry compliance standards

• EN 71-3 (Safety of Toys – migration of certain elements, for pigment use in toys)
• Oeko-Tex Standard 100 (textile safety)
• ISO 9001:2015 for manufacturing quality systems
• Chinese National Standard GB/T 25814 for dye intermediates

Typical usage ratio

• 5–18% of reaction mass, typically optimized in pilot runs according to the color depth, shade, and pigment matrix

Downstream process integration

• Entry as primary aromatic precursor for condensation or azo coupling in pigment/dye synthesis workflow

Final product types

• Specialty azo dyes for synthetic fibers and plastics
• Organic pigments for coatings and inks

4. Chemical Intermediate for Veterinary Drug Synthesis

Animal health product manufacturers incorporate 5-Chloro-3-Methyl-1-Phenylpyrazole in multi-step synthesis of selective pyrazole-based antiparasitic and anti-inflammatory veterinary actives. The material’s consistent quality supports reliable downstream functionalization and scale-up, reducing batch-to-batch variability for GMP-compliant finished formulations destined for regional and global animal pharmaceutical markets.

Industry compliance standards

• VICH GL10 (Good Manufacturing Practice for veterinary pharmaceutical products)
• US FDA 21 CFR Part 226 (GMP for Medicated Feed Manufacturing)
• European Directorate for the Quality of Medicines & HealthCare (EDQM) for veterinary APIs
• Chinese Veterinary Pharmacopoeia

Typical usage ratio

• 8–15% of input relies on pharmacokinetic design of the antiparasitic or anti-inflammatory agent sought by the end-user

Downstream process integration

• Intermediate fed into pyrazole ring closure and subsequent selective substitution reactions in veterinary API production pipelines

Final product types

• Bulk veterinary actives with pyrazole pharmacophores
• Premixed oral and injectable animal drug formulations